Fairfax Financial Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FXFLF research report →
Price Chart
About the company
Fairfax Financial Holdings Limited operates as a diversified holding company, primarily engaged in property and casualty insurance and reinsurance, in addition to providing investment management services. Its global reach spans the United States, Canada, Asia, and other international territories. The company organizes its operations across distinct segments: Insurance and Reinsurance, Run-off activities, and a portfolio of Non-Insurance Companies.
- CEO
- V. Prem Watsa
- IPO
- 2010
- Employees
- 47,040
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on FXFLF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $16.84B
- P/E
- 8.88
- PEG
- -1.80
- P/S
- 1.04
- P/B
- 1.35
- EV/EBITDA
- 6.10
- Div Yield
- 0.79%
- Gross Margin
- 69.91%
- Op Margin
- 16.77%
- Net Margin
- 11.53%
- ROE
- 15.98%
- ROIC
- 5.02%
Latest fiscal year · YoY change
- Revenue
- $31.83B+23.3%
- Gross Profit
- $31.34B+21.4%
- Op Income
- $31.40B
- Net Income
- $4.38B+282.0%
- EPS
- $176.42+30.4%
- OCF Growth
- +99.1%
- FCF Growth
- +88.6%
- 52W High
- $16.62
- 52W Low
- $14.73
- 50D MA
- $16.54
- 200D MA
- $16.06
- Beta
- 0.82
- RSI (14)
- 85
- Avg Volume
- 119
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Fairfax delivered another strong underwriting quarter, with book value up 8.4% year to date despite mark-to-market investment losses, while international premium growth and M&A activity remained important themes.· November 4, 2026
- Operating income from insurance and reinsurance was $1.4 billion, up from $1.3 billion a year ago, while underwriting income was $524 million with a 92.5% combined ratio.
- Net earnings were $930 million in the quarter and $3 billion for the first nine months, but investment results swung to an $859 million net loss versus $426 million of gains last year on higher rates.
- Gross premiums grew 9.3% to $8.9 billion, led by international operations up 27.1% and helped by stronger pricing and growth at Gulf, Brit, and Fairfax Asia.
- Book value per share ended at $1,349, up 8.4% from year-end 2025 after dividends.
- Capital remained strong, with $1.9 billion at the holding company, $2 billion of undrawn revolver capacity, and $5.1 billion of pre-tax excess fair value over carrying value in associates and market-traded holdings.
Fairfax reported net earnings of $930 million for Q3 2026 and $3 billion for the first nine months. Operating income from insurance and reinsurance, adjusted to an undiscounted basis and before risk margin, was $1.4 billion, up from $1.3 billion in Q3 2025. Underwriting income was $524 million versus $540 million a year ago, with a combined ratio of 92.5% compared with 92.0% last year. Consolidated interest and dividend income was $669 million, up 2% year over year from $655 million, and profits of associates were $378 million versus $305 million. Net investment results were a loss of $859 million, versus gains of $426 million in Q3 2025, driven mainly by unrealized bond losses from higher interest rates. Book value per share was $1,349 at September 30, 2026, up 8.4% from year-end 2025 after adjusting for the $15 dividend. Gross premium written was $8.9 billion, up 9.3% year over year, and annualized gross premium run rate was described as almost $35 billion. Looking ahead, management said fourth-quarter reserve reviews are underway and that capital dividends to the holding company should increase as year-end capital positions are reviewed; no formal quarterly or full-year earnings guidance was given.
Peter Clarke said Fairfax had another strong quarter, emphasizing underwriting discipline, diversified growth, and long-term capital strength. He highlighted that growth is increasingly coming from international operations, while North American markets remain softer, especially in property and reinsurance. He also pointed to several transactions and strategic moves, including Eurolife’s sale, the selected bid for IDBI Bank, and the Boots partnership, framing them as part of Fairfax’s long-term compounder approach.
Amy Sherk detailed the quarter’s balance-sheet strength and recent transactions. She said the company held $1.9 billion of cash and investments at the holding company, had access to a $2 billion undrawn revolver, and had $5.1 billion of pre-tax excess fair value over carrying value in non-insurance associates and market-traded subsidiaries, including $3.6 billion related to Eurobank and $0.8 billion to Poseidon. She also noted common shareholders’ equity of $26.9 billion, debt to total capital of 27.3%, and book value per share of $1,349.15, up 8.4% year to date after dividends.
Analysts focused on IDBI Bank, capital allocation, investment income, and growth trends. On IDBI, Peter Clarke said the transaction is not closed and there was little more to add beyond prior disclosures. On capital allocation, he said fourth quarter is a key period for reviewing capital and dividends from operating subsidiaries, and that slower growth in recent years means more excess capital is now being generated. On interest income and growth, management said the quarter’s interest and dividend income was roughly flat year over year because dividends were lighter in Q3, while premium growth acceleration was mostly not a new market shift but rather the continuation of softer North American conditions and stronger international growth.
The core insurance and reinsurance businesses remained profitable, with a 92.5% combined ratio and favorable reserve development of $156 million. Fairfax also has meaningful liquidity and capital flexibility, and management believes the portfolio is positioned to benefit from a higher-rate environment while still locking in income if rates fall. International underwriting growth and several strategic transactions suggest multiple avenues for longer-term earnings and book value growth.
Investment marks were a headwind this quarter, with $859 million of net losses tied mainly to bond markdowns from higher rates. Management repeatedly noted softer conditions in North American property and reinsurance, and some international operations still had combined ratios above 100%, including Eurolife, Falcon Thailand, and Fairfirst in Sri Lanka. The IDBI Bank deal remains subject to regulatory approval, and the Boots transaction is not expected to close until the first quarter of 2027.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 1.9%
- Shares Outstanding
- 1.01B
- Float Shares
- 19.65M
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 13, 23 | WATSA V PREM ET AL | other | 1 |
| Nov 13, 23 | WATSA V PREM ET AL | sell | 1 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FXFLF coverage
Recent articles, reports, and earnings notes.
No research on FXFLF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FXFLF report →